Brian C. Evanko - 01 Sep 2026 Form 4 Insider Report for Cigna Group (CI)

Reporting relationship: President and Chief Executive Officer
Issuer ticker: CI
Reported as of: 01 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Sep 2026, 16:21:44 UTC
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: Tyler Gratton, attorney-in-fact

Key filing fact

Brian C. Evanko filed Form 4 for Cigna Group (CI) on 03 Sep 2026.

Key facts

This page summarizes Brian C. Evanko's Form 4 filing for Cigna Group (CI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Sep 2026, 16:21.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001722909 Primary reporting owner

Evanko Brian C

Relationship: President and Chief Executive Officer
Address: 900 COTTAGE GROVE ROAD, BLOOMFIELD
Signature: Tyler Gratton, attorney-in-fact
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Award

Transaction value
Shares: +3,113
Change %: +8.2%
Price: $0.000000^*
Shares after: 41,030
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,614
Date: 01 Sep 2026
Ownership: By GRAT

CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 920
Date: 01 Sep 2026
Ownership: By 401(k)
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +6,716
Change %
Price: $0.000000^*
Shares after: 6,716
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock, $0.01 Par Value
Underlying amount: 6,716
Exercise price: $281.13
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These restricted shares vest in three equal annual installments beginning September 1, 2027.

Footnote F2

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F3

This option vests in three equal annual installments beginning September 1, 2027.

SEC remarks

President and Chief Executive Officer